Resultados del tratamiento de nevos melanocíticos con láser


Autoria(s): Leal Sandoval, Tatiana
Contribuinte(s)

Ríos-Mora, Carlos-Adrian

Morón Duarte, Lina Sofía

Ibáñez-Pinilla, Milcíades

Data(s)

20/12/2013

Resumo

Introducción A pesar de que los nevos melanocíticos son un motivo de consulta frecuente en nuestra población no existen estudios a nivel de Colombia acerca de su tratamiento, a nivel mundial existe muy poca literatura al respecto por lo que hay un vacío conceptual en este campo. Objetivos Evaluar los cambios en cuanto a la presencia de pigmento y cicatrización, en los nevos melanocíticos adquiridos tratados con láser, basados en la experiencia de un solo centro en Bogotá. Materiales y métodos Es un estudio observacional de antes y después, en una cohorte histórica, de 90 casos de nevos melanocíticos adquiridos, tratados con láser en Uniláser Medica, en los que se evaluó la presencia de pigmento, cicatrización, y otras variables, con un control realizado a no menos de 3 meses de la intervención. Resultados Se encontró un rango de edad entre los 18 -51 años, promedio 27,59 años; fototipo de III-V; en el 32% de los casos, solo fue requerida una sesión de láser de Co2 y Erbio, para el aclaramiento completo de la misma. La duración del eritema en el 54,4% los casos fue de 1 a 3 meses. En un 64,4% quedó pigmento residual al control, pero de éstos casos el 48,2% fue entre un 5 a un 10% del inicial. El 58,9% hizo cicatriz, de éstos el 63% fue estética. La satisfacción por parte de los pacientes es alta a pesar de la persistencia pigmentaria y/o la presencia de cicatriz. Discusión El tratamiento de nevos melanocíticos adquiridos con láser es una opción terapéutica que genera cambios estadísticamente significativos en cuanto a pigmento, cicatriz estética y alta satisfacción por parte de los pacientes. Se requieren estudios, analíticos, para determinar eficacia del tratamiento.

Introduction Although melanocytic nevi are a frequent complaint in our population, no studies in Colombia about your treatment, globally there is little literature on the subject so that there is a conceptual gap in this field. Objectives Evaluate changes in pigment reduction and scarring in acquired melanocytic nevi laser treated. Materials and methods It is an observational study of before and after, in a historical cohort of 90 cases of acquired melanocytic nevi treated with laser in Unilaser Medica, in which we assessed the presence of pigment, scarring, and other variables, with a check carried out at not less than 3 months of intervention. Results There was an age range between 18 -51 years , mean 27.59 years ; phototype III- V , in 32% of cases , only one session was required CO2 and Erbium laser for full clearance. The duration of the erythema in 54.4 % of cases was 1 to 3 months. Was 64.4% in residual pigment control, but of these cases was 48.2% from 5 to 10 % of baseline. The scar was 58.9 %, of these 63 % were aesthetic scar. The satisfaction of patients is high despite the persistent pigment and / or the presence of scar. Discussios Treatment of acquired melanocytic nevi with laser is a treatment option that generates statistically significant changes in terms of pigment, scar aesthetics and high satisfaction among patients. Analytical studies, are required to determine treatment efficacy.

Formato

application/pdf

Identificador

http://repository.urosario.edu.co/handle/10336/4938

Idioma(s)

spa

Publicador

Facultad de Medicina

Direitos

info:eu-repo/semantics/openAccess

Fonte

reponame:Repositorio Institucional EdocUR

instname:Universidad del Rosario

Happle R. What is a nevus? A proposed definition of a common medical term. Dermatology. 1995;191:1–5

Worret WI, Which direction do nevus cells move? Abtropfung reexamined. Am J Dermatopathol. 1998;20:135–139.

Ackerman AB, Naming acquired melanocytic nevi.Unna’s, Miescher’s, Spitz’s Clark’s. Am J Dermatopathol. 1990;12:193–209.

Madan V, Non melanoma skin cáncer. Lancet. 2010 Feb 20;375(9715):673-85.

Kopf AW, A histological study of the dermoepidermal junction in clinically ‘‘intradermal’’ nevi employing serial sections.I. Junctional theques. Ann NY Acad Sci. 1963;100:200–21.

Elder DE, Benign pigmented lesions and malignant melanoma. In: Elder DE, Elenitsas R, Jaworsky Ch, et al, editors. Lever’s Histopathology of the Skin. 8th ed. Philadelphia: Lippincott-Raven; 1997:625–84.

Barnhill RL. Tumors of melanocytes. In: Barnhill RL, editor. Textbook of Dermatopathology. New York: Mc Graw Hill; 1998:537–91.

Barnhill RL. Tumors of melanocytes. In: Barnhill RL, editor. Textbook of Dermatopathology. New York: Mc Graw Hill; 1998:537–91.

Del Cerro M, Unna’s and Miescher’s Nevi: Two Different Types of Intradermal Nevus: Hypothesis Concerning Their Histogenesis. Am J Dermatopathol 2007;29:141–151.

Kaminska - Winciore, G. Tips and tricks in the dermoscopy of pigmented lesions. BMC Dermatology 2012, 12: 14 – 20.

Bafounta ML, Is dermatoscopy ( epiluminiscence microscopy) useful for the diagnosis of melanoma? Results of a meta-analysis using techniques adapted to the evaluation of diagnostic tests. Arch Dermatol 2001; 137: 1343-1350.

Bono A, Micro-melanoma detection. A clinical study on 22 cases of melanoma with a diameter equal to or less than 3 mm. Tumori 2004, 90: 128-131.

Bono A, Micro-melanoma detection: a clinical study on 206 consecutive cases of pigmented skin lesions with a diameter < or = 3 mm. Br J Dermatol 2006, 155: 570 – 3.

Zalaudek I, Age distribution of biopsied junctional nevi-Unna´s concept versus a dual concept of nevogenesis. J Am Acad Dermatol 2007, 57: 1096-1097.

Zalaudek I, Age related prevalence of dermoscopy patterns in acquired melanocytic naevi. Br J Dermatol 2006, 154: 299-304.

Salerni, G, Meta-analysis of digital dermoscopy follow-up of melanocytic skin lesions: a study on behalf of the International Dermoscopy Society. Journal Europ Acad Dermatol Venereol.

Stolz, W, Color Atlas of Dermatoscopy, Blackwell Publishing, 1994. Pag 11-54

Allington H. Liquid nitrogen in the treatment of skin diseases. CalifMed 1950;72:153-5

Hocutt JE Jr. Skin cryosurgery for the family physician. Am Fam Physician 1993;48(3):445-52,455-6.

Wetmore, S. Cryosurgery for common skin lesions treatment in family physicians offices. Can Fam Physician 1999;45:964

Sharma VK, Guidelines for cryotherapy. Indian J Dermatol Venereol Leprol. 2009;75:90-100.

Valiukeviciene,S. The prevalence of common acquired melanocytic nevi and the relationship with tkin type characteristics and sun exposure among children in Lithuania. Arch Dermatol. 2005;141:579-586.

Rex,J. Nevus Melanocíticos. Protocolos diagnósticos y terapéuticos en dermatología pediátrica. Ed. Esmón.2007. Barcelona .Pag 175-183.

Goldberg, D. Laser and Lights: Volume I, Editorial Elsevier. Madrid . Pag 1-68.

Reda, A. Clinical and histological effect of a single treatment of normal mode alexandrite (755 nm) laser on small melanocytic nevi. Journal of Cutaneous Laser Therapy 1999; 1: 209±215.

Garbe C, Risk factors for developing cutaneous melanoma and criteria for identifying persons at risk: multicenter case control study of the central malignant melanoma registry of the German dermatological society. J Invest Dermatol. 1994; 102: 695 – 699.

Carli P, Biggeri A, Malignant melanoma in Italy: risk associated with common and clinically atypical melanocytic nevi. J Am Acad Dermatol. 1995; 32: 734-739.

Naldi L, Pigmentary traits, modalities of sun reaction, history of sunburns, and melanocytic nevi as risk factors for cutaneous malignant melanoma in the Italian population: results of a collaborative case-control study. Cancer. 2000; 88:2703 – 2710.

Skender-Kahrenas, T. Benign melanocytic lesions: Risk markers or precursors of cutaneous melanoma? J Am Acad Dermatol 1995; 33: 1000-7.

Suzuki, H. Treatment of melanocytic nevi, Dermatologic Therapy, Vol. 18, 2005, 217– 226.

Dal’Forno T, Dermabrasion in Acquired Melanocytic Nevi: A Histopathological and Immunohistochemical Study, Am J Dermatopathol 2011;33:40–46.

Robinson JK. Excision of benign pigmented nevi by shave technique. J Dermatol Surg Oncol 1980;3-6.

Bong JL, Shave excision of benign facial melanocytic naevi: a patient’s satisfaction survey. Dermatol Surg 2003; 29: 227–9.

Hudson-Peacock MJ, Shave excision of benign popular naevocytic naevi. Br J Plast Surg 1995;48: 318–22.

Tursen U. Round excision of small, benign, papular and dome‐shaped melanocytic nevi on the face, International Journal of Dermatology 2004,43, 844 –846.

Lara F, Shave Excision of Common Acquired Melanocytic Nevi: Cosmetic Outcome, Recurrences, and Complications. Dermatol Surg 2005;31:1112–1115.

Ji Yeon Lim, A Combination of Dual-mode 2,940 nm Er:YAG Laser Ablation with Surgical Excision for Treating Medium sized Congenital Melanocytic Nevus, Ann Dermatol 21(2) 120-124, 2009.

Baba,M. Efficacy and Safety of Short-Pulse Erbium:YAG Laser in the Treatment of Acquired Melanocytic Nevi. Dermatol Surg 2006;32:256–260.

Kim, Y. Efficacy and Safety of 1,064 nm Q-switched Nd:YAG Laser Treatment for Removing Melanocytic Nevi. Ann Dermatol 24(2) 162-167, 2012.

Polder, K. Laser Erradication of pigmented lesions: A review. Dermatol Surg 2011; 37:572-595.

Rosenbach, Alan. Comparison of the Q-Switched Alexandrita and Q-Switched Nd –Yag lasers in the treatment of benign melanocytic nevi. Dermatol Surg 1997; 23 : 239-245.

Palavras-Chave #NEVOS Y MELANOMAS - DIAGNÓSTICO #NEVOS Y MELANOMAS - TRATAMIENTO #RAYOS LÁSER - EFECTOS ADVERSOS #Melanocytic Nevi #Laser
Tipo

info:eu-repo/semantics/bachelorThesis

info:eu-repo/semantics/acceptedVersion